Global and China Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Insights, Forecast to 2027

Global and China Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Product Introduction
1.2 Market by Type
1.2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size Growth Rate by Type
1.2.2 1g/20ml
1.2.3 1.25g/25ml
1.2.4 2.5g/50ml
1.2.5 5g/100ml
1.2.6 10g/200ml
1.3 Market by Application
1.3.1 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size, Estimates and Forecasts
2.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue 2016-2027
2.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales 2016-2027
2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Historical Market Size by Region (2016-2021)
2.3.1 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Forecast by Region (2022-2027)
2.4.2 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Forecast by Region (2022-2027)
3 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Competitor Landscape by Players
3.1 Global Top Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Manufacturers by Sales
3.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Manufacturer (2016-2021)
3.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Manufacturers by Revenue
3.2.1 Key Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Manufacturers (2016-2021)
3.2.3 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue in 2020
3.2.6 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Price by Manufacturers
3.4 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Manufacturing Base Distribution, Product Types
3.4.1 Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Product Type
3.4.3 Date of International Manufacturers Enter into Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size by Type (2016-2021)
4.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Type (2016-2021)
4.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Type (2016-2021)
4.1.3 Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size Forecast by Type (2022-2027)
4.2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Forecast by Type (2022-2027)
4.2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Forecast by Type (2022-2027)
4.2.3 Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size by Application (2016-2021)
5.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Application (2016-2021)
5.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Application (2016-2021)
5.1.3 Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Price by Application (2016-2021)
5.2 Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size Forecast by Application (2022-2027)
5.2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Forecast by Application (2022-2027)
5.2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size YoY Growth 2016-2027
6.1.1 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales YoY Growth 2016-2027
6.1.2 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue YoY Growth 2016-2027
6.1.3 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Share in Global Market 2016-2027
6.2 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size by Players (International and Local Players)
6.2.1 China Top Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Players by Sales (2016-2021)
6.2.2 China Top Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Players by Revenue (2016-2021)
6.3 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Historic Market Review by Type (2016-2021)
6.3.1 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Market Share by Type (2016-2021)
6.3.2 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Market Share by Type (2016-2021)
6.3.3 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Price by Type (2016-2021)
6.4 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Forecast by Type (2022-2027)
6.4.2 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Forecast by Type (2022-2027)
6.4.3 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Price Forecast by Type (2022-2027)
6.5 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Historic Market Review by Application (2016-2021)
6.5.1 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Market Share by Application (2016-2021)
6.5.2 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Market Share by Application (2016-2021)
6.5.3 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Price by Application (2016-2021)
6.6 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Forecast by Application (2022-2027)
6.6.2 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Forecast by Application (2022-2027)
6.6.3 China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Price Forecast by Application (2022-2027)
7 North America
7.1 North America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size YoY Growth 2016-2027
7.2 North America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Facts & Figures by Country
7.2.1 North America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Country (2016-2021)
7.2.2 North America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Facts & Figures by Region
8.2.1 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Region (2016-2021)
8.2.2 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size YoY Growth 2016-2027
9.2 Europe Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Facts & Figures by Country
9.2.1 Europe Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Country (2016-2021)
9.2.2 Europe Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size YoY Growth 2016-2027
10.2 Latin America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Facts & Figures by Country
10.2.1 Latin America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Country (2016-2021)
10.2.2 Latin America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Boya-Bio
12.1.1 Boya-Bio Corporation Information
12.1.2 Boya-Bio Description and Business Overview
12.1.3 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Products Offered
12.1.5 Boya-Bio Recent Development
12.2 Beijing Tiantan Biological Products
12.2.1 Beijing Tiantan Biological Products Corporation Information
12.2.2 Beijing Tiantan Biological Products Description and Business Overview
12.2.3 Beijing Tiantan Biological Products Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Beijing Tiantan Biological Products Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Products Offered
12.2.5 Beijing Tiantan Biological Products Recent Development
12.3 Hualan Bio
12.3.1 Hualan Bio Corporation Information
12.3.2 Hualan Bio Description and Business Overview
12.3.3 Hualan Bio Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Hualan Bio Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Products Offered
12.3.5 Hualan Bio Recent Development
12.4 Guangdong Shuagnlin Bio-pharmacy
12.4.1 Guangdong Shuagnlin Bio-pharmacy Corporation Information
12.4.2 Guangdong Shuagnlin Bio-pharmacy Description and Business Overview
12.4.3 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Products Offered
12.4.5 Guangdong Shuagnlin Bio-pharmacy Recent Development
12.5 Weiguang Biological
12.5.1 Weiguang Biological Corporation Information
12.5.2 Weiguang Biological Description and Business Overview
12.5.3 Weiguang Biological Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Weiguang Biological Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Products Offered
12.5.5 Weiguang Biological Recent Development
12.6 Sinopharm
12.6.1 Sinopharm Corporation Information
12.6.2 Sinopharm Description and Business Overview
12.6.3 Sinopharm Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sinopharm Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Products Offered
12.6.5 Sinopharm Recent Development
12.7 Shanghai RAAS
12.7.1 Shanghai RAAS Corporation Information
12.7.2 Shanghai RAAS Description and Business Overview
12.7.3 Shanghai RAAS Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Shanghai RAAS Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Products Offered
12.7.5 Shanghai RAAS Recent Development
12.8 CTBB
12.8.1 CTBB Corporation Information
12.8.2 CTBB Description and Business Overview
12.8.3 CTBB Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CTBB Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Products Offered
12.8.5 CTBB Recent Development
12.9 Nanyue Biopharming
12.9.1 Nanyue Biopharming Corporation Information
12.9.2 Nanyue Biopharming Description and Business Overview
12.9.3 Nanyue Biopharming Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Nanyue Biopharming Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Products Offered
12.9.5 Nanyue Biopharming Recent Development
12.11 Boya-Bio
12.11.1 Boya-Bio Corporation Information
12.11.2 Boya-Bio Description and Business Overview
12.11.3 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Products Offered
12.11.5 Boya-Bio Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Industry Trends
13.2 Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Drivers
13.3 Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Challenges
13.4 Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 1g/20ml
Table 3. Major Manufacturers of 1.25g/25ml
Table 4. Major Manufacturers of 2.5g/50ml
Table 5. Major Manufacturers of 5g/100ml
Table 6. Major Manufacturers of 10g/200ml
Table 7. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 8. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Regions (2016-2021) & (K Units)
Table 10. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Market Share by Regions (2016-2021)
Table 11. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Forecast by Region (2022-2027) & (K Units)
Table 13. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Manufacturers (2016-2021) (K Units)
Table 17. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Manufacturers by Revenue (US$ Million) in 2020
Table 19. Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Share by Manufacturers (2016-2021)
Table 21. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) as of 2020)
Table 23. Key Manufacturers Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Price (2016-2021) (US$/Unit)
Table 24. Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Product Type
Table 26. Date of International Manufacturers Enter into Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Type (2016-2021) (K Units)
Table 29. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Share by Type (2016-2021)
Table 30. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Share by Type (2016-2021)
Table 32. Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 33. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Forecast by Type (2022-2027) & (K Units)
Table 34. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 38. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Application (2016-2021) (K Units)
Table 39. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Share by Application (2016-2021)
Table 40. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Share by Application (2016-2021)
Table 42. Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 43. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Forecast by Application (2022-2027) & (K Units)
Table 44. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 48. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales (K Units) of Key Companies (2016-2021)
Table 49. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Share by Company (2016-2021)
Table 50. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue (US$ Million) by Company (2016-2021)
Table 51. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Share by Company (2016-2021)
Table 52. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales (K Units) by Type (2016-2021)
Table 53. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Share by Type (2016-2021)
Table 54. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Price (US$/Unit) by Type (2016-2021)
Table 56. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales (K Units) by Type (2022-2027)
Table 57. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Share by Type (2022-2027)
Table 58. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Share by Type (2022-2027)
Table 60. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Price (US$/Unit) by Type (2022-2027)
Table 61. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales (K Units) by Application (2016-2021)
Table 62. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Share by Application (2016-2021)
Table 63. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Price (US$/Unit) by Application (2016-2021)
Table 65. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales (K Units) by Application (2022-2027)
Table 66. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Share by Application (2022-2027)
Table 67. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Share by Application (2022-2027)
Table 69. China Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Price (US$/Unit) by Application (2022-2027)
Table 70. North America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Country (2016-2021) & (K Units)
Table 71. North America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Market Share by Country (2016-2021)
Table 72. North America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Region (2016-2021) & (K Units)
Table 75. Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Market Share by Region (2016-2021)
Table 78. Europe Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Country (2016-2021) & (K Units)
Table 79. Europe Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Market Share by Country (2016-2021)
Table 80. Europe Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Market Share by Country (2016-2021)
Table 82. Latin America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Country (2016-2021) & (K Units)
Table 83. Latin America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales by Country (2016-2021) & (K Units)
Table 87. Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Revenue Market Share by Country (2016-2021)
Table 90. Boya-Bio Corporation Information
Table 91. Boya-Bio Description and Business Overview
Table 92. Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 93. Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Product
Table 94. Boya-Bio Recent Development
Table 95. Beijing Tiantan Biological Products Corporation Information
Table 96. Beijing Tiantan Biological Products Description and Business Overview
Table 97. Beijing Tiantan Biological Products Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 98. Beijing Tiantan Biological Products Product
Table 99. Beijing Tiantan Biological Products Recent Development
Table 100. Hualan Bio Corporation Information
Table 101. Hualan Bio Description and Business Overview
Table 102. Hualan Bio Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 103. Hualan Bio Product
Table 104. Hualan Bio Recent Development
Table 105. Guangdong Shuagnlin Bio-pharmacy Corporation Information
Table 106. Guangdong Shuagnlin Bio-pharmacy Description and Business Overview
Table 107. Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Guangdong Shuagnlin Bio-pharmacy Product
Table 109. Guangdong Shuagnlin Bio-pharmacy Recent Development
Table 110. Weiguang Biological Corporation Information
Table 111. Weiguang Biological Description and Business Overview
Table 112. Weiguang Biological Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Weiguang Biological Product
Table 114. Weiguang Biological Recent Development
Table 115. Sinopharm Corporation Information
Table 116. Sinopharm Description and Business Overview
Table 117. Sinopharm Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Sinopharm Product
Table 119. Sinopharm Recent Development
Table 120. Shanghai RAAS Corporation Information
Table 121. Shanghai RAAS Description and Business Overview
Table 122. Shanghai RAAS Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Shanghai RAAS Product
Table 124. Shanghai RAAS Recent Development
Table 125. CTBB Corporation Information
Table 126. CTBB Description and Business Overview
Table 127. CTBB Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. CTBB Product
Table 129. CTBB Recent Development
Table 130. Nanyue Biopharming Corporation Information
Table 131. Nanyue Biopharming Description and Business Overview
Table 132. Nanyue Biopharming Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Nanyue Biopharming Product
Table 134. Nanyue Biopharming Recent Development
Table 135. Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Trends
Table 136. Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Drivers
Table 137. Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Challenges
Table 138. Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Market Restraints
Table 139. Human Immunoglobulin(pH4) for Intravenous Injection(COVID-19) Customers List
Table 140. Human Immunoglobulin(pH4) for Intravenous Injection(CO

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs